- Home
- FSTR vs LYEL Comparison
FSTR vs LYEL Comparison
Compare FSTR & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSTR
- LYEL
- Stock Information
- Founded
- FSTR 1902
- LYEL 2018
- Country
- FSTR United States
- LYEL United States
- Employees
- FSTR N/A
- LYEL N/A
- Industry
- FSTR Metal Fabrications
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- FSTR Industrials
- LYEL Health Care
- Exchange
- FSTR Nasdaq
- LYEL Nasdaq
- Market Cap
- FSTR 239.1M
- LYEL 207.7M
- IPO Year
- FSTR N/A
- LYEL 2021
- Fundamental
- Price
- FSTR $27.19
- LYEL $13.03
- Analyst Decision
- FSTR Hold
- LYEL Sell
- Analyst Count
- FSTR 1
- LYEL 2
- Target Price
- FSTR $25.00
- LYEL $15.00
- AVG Volume (30 Days)
- FSTR 38.3K
- LYEL 25.9K
- Earning Date
- FSTR 11-06-2025
- LYEL 11-06-2025
- Dividend Yield
- FSTR N/A
- LYEL N/A
- EPS Growth
- FSTR 395.33
- LYEL N/A
- EPS
- FSTR 3.32
- LYEL N/A
- Revenue
- FSTR $506,999,000.00
- LYEL $60,000.00
- Revenue This Year
- FSTR $4.25
- LYEL N/A
- Revenue Next Year
- FSTR $3.61
- LYEL N/A
- P/E Ratio
- FSTR $8.00
- LYEL N/A
- Revenue Growth
- FSTR N/A
- LYEL 11.11
- 52 Week Low
- FSTR $17.16
- LYEL $7.65
- 52 Week High
- FSTR $29.78
- LYEL $32.00
- Technical
- Relative Strength Index (RSI)
- FSTR 64.58
- LYEL 72.26
- Support Level
- FSTR $26.16
- LYEL $10.76
- Resistance Level
- FSTR $27.37
- LYEL $11.67
- Average True Range (ATR)
- FSTR 0.96
- LYEL 0.57
- MACD
- FSTR 0.27
- LYEL 0.17
- Stochastic Oscillator
- FSTR 96.44
- LYEL 100.00
About FSTR L.B. Foster Company
L.B. Foster Co is a U.S-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.